Intelligence / Healthtech / De Novo Grants / Cathbuddy, Inc.
Approvalsnovel device granted (FDA De Novo)30 Apr 2026
Cathbuddy, Inc.
30 Apr 2026: Novel device granted (FDA De Novo) · Aurie System. Recorded in the openFDA device 510(k) (De Novo decisions).
- Granted
- 30 Apr 2026
- Device
- Aurie System
- Specialty
- Gastroenterology, Urology
- Product Code
- SHV
- Country
- United States
- Location
- Syracuse, NY
- Submitted
- 2025-06-06
- Reference
- DEN250023
What this signal means
A De Novo grant creates a new device category: reimbursement coding, distribution, clinical evidence, manufacturing scale-up and sales hires follow.
- 2 added in the 30 days to 19 Nov 2026.
- Neurology leads (10); 29% went to makers outside the US.
Reach them with AOS
Find the decision makers at Cathbuddy, Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
More in Gastroenterology, Urology
De Novo Grants
20 AugCm Technologies, Inc.novel device granted (FDA De Novo) · Qoramatic Automated Stool ManagementApprovals15 JanBridge TO Life, Ltd.novel device granted (FDA De Novo) · VitaSmart Hypothermic Oxygenated Perfusion SystemApprovals17 OctNeurovalens Limitednovel device granted (FDA De Novo) · Modius LeanApprovals
Source: openFDA device 510(k) (De Novo decisions), data to 19 Nov 2026. Every De Novo classification FDA granted in the last 24 months: a novel device with no legally marketed predicate, which creates a new device type and product code. AOS shows what the public record says; it does not verify or endorse the company.